Profil
Matthew R.
Hooper is a member of The State Bar of California and the Illinois State Bar Association.
He previously worked as a Patent Counsel at Abbott Laboratories from 1994 to 1999, a Vice President-Law at Scios, Inc. from 2000 to 2006, and a Vice President & General Counsel at Halozyme Therapeutics, Inc. He also worked as a Patent Attorney at Amoco Corp.
from 1985 to 1994 and as a Senior Counsel-Litigation Group at Jones Day Foundation from 1999 to 2000.
He was also a Senior VP-Legal Affairs & General Counsel at Coherus BioSciences, Inc. from 2012 to 2013.
Mr. Hooper is a graduate of Northwestern University and holds an undergraduate degree from LaSalle University.
Aktive Positionen von Matthew R. Hooper
| Unternehmen | Position | Beginn |
|---|---|---|
The State Bar of California
The State Bar of California Miscellaneous Commercial ServicesCommercial Services Operates as a official attorney licensing agency | Corporate Officer/Principal | - |
Illinois State Bar Association
Illinois State Bar Association Miscellaneous Commercial ServicesCommercial Services Operates as legal association | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Matthew R. Hooper
| Unternehmen | Position | Ende |
|---|---|---|
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures & commercializes pharmaceuticals | General Counsel | 01.01.2006 |
Jones Day Foundation
Jones Day Foundation Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Corporate Officer/Principal | 01.01.2000 |
| ABBOTT LABORATORIES | Corporate Officer/Principal | 01.01.1999 |
Amoco Corp.
Amoco Corp. Oil Refining/MarketingEnergy Minerals Explores for, develops, produces, and refines crude oil and natural gas | Corporate Officer/Principal | 01.01.1994 |
California State Bar Association | Corporate Officer/Principal | - |
Ausbildung von Matthew R. Hooper
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 12 |
|---|---|
Abbott Laboratories
Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
Johnson & Johnson
Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures & commercializes pharmaceuticals | Health Technology |
Halozyme Therapeutics, Inc.
Halozyme Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of recombinant human enzymes for the infertility, ophthalmology & oncology markets | Health Technology |
Amoco Corp.
Amoco Corp. Oil Refining/MarketingEnergy Minerals Explores for, develops, produces, and refines crude oil and natural gas | Energy Minerals |
Northwestern University
Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LaSalle University
LaSalle University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Jones Day Foundation
Jones Day Foundation Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
The State Bar of California
The State Bar of California Miscellaneous Commercial ServicesCommercial Services Operates as a official attorney licensing agency | Commercial Services |
California State Bar Association | |
Illinois State Bar Association
Illinois State Bar Association Miscellaneous Commercial ServicesCommercial Services Operates as legal association | Commercial Services |
Coherus BioSciences, Inc.
Coherus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial-stage biopharmaceutical company that engages in research, development and commercialization of immunotherapies to treat cancer | Health Technology |
















